![]() |
|
|
Vol. 54, Issue 5, 761-769, November 1998
Departments of
Pharmacology and Toxicology (L.J.O., B.Y.H., J.G.D.)
and
Microbiology (L.W.C.), Medical College of Wisconsin, Milwaukee,
Wisconsin 53226, and
Department of Pharmacology and Toxicology,
University of North Dakota School of Medicine and Health Sciences,
Grand Forks, North Dakota 58202 (B.Y.H., J.G.D.)
An aspartate-to-alanine point mutation in the catalytic domain (D853A)
of guanylyl cyclase-C (GC-C), the heat-stable enterotoxin (STa)
receptor, rendered the enzyme catalytically inactive.
Mn2+/Triton X-100-stimulated guanylyl cyclase activity was
detected in membranes from COS7 cells overexpressing GC-C but not
GC-CD853A. STa treatment of paired cells resulted in cGMP production in
those transiently expressing GC-C but not GC-CD853A. GC-C and GC-CD853A showed similar Bmax and
Kd values for
[125I]STa binding in these cells, indicating that the
lack of catalytic activity in the latter was not due to differing
expression levels or reduced binding affinity. The involvement of the
catalytic domain in aldosteronogenesis was studied in human
adrenocortical H295R cells. COS7 and H295R cells infected with vaccinia
virus-expressing GC-C and GC-CD853A (VVGC-CD853A) had
[125I]STa-binding characteristics akin to those in
transfected cells. Immunoblot confirmed that both GC-C and GC-CD853A
formed similar higher order oligomers in infected cells. Virus-mediated
expression of GC-C in H295R cells revealed concentration-dependent
STa-stimulated cGMP formation that was undetectable in
VVGC-CD853A-infected cells. STa decreased angiotensin II-stimulated
human aldosterone generation in a concentration-dependent manner in
vaccinia virus-expressing GC-C-infected cells but not in those infected
with VVGC-CD853A. These results demonstrate that a catalytically active
guanylyl cyclase is required for the inhibition of aldosteronogenesis.
This article has been cited by other articles:
![]() |
D. Zhao, E. Vellaichamy, N. K. Somanna, and K. N. Pandey Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels Am J Physiol Renal Physiol, July 1, 2007; 293(1): F121 - F127. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Veltman and P. J.M. Van Haastert Guanylyl Cyclase Protein and cGMP Product Independently Control Front and Back of Chemotaxing Dictyostelium Cells Mol. Biol. Cell, September 1, 2006; 17(9): 3921 - 3929. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF] |
||||